Biogen
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1978-01-01
- Employees
- 7.5K
- Market Cap
- $29.6B
- Website
- https://www.biogen.com
- Introduction
Biogen, Inc. is a biopharmaceutical company, which engages in discovering, developing, and delivering therapies for neurological and neurodegenerative diseases. Its products include TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI and FAMPYRA for the treatment of MS, SPINRAZA for the treatment of SMA, ADUHELM for the treatment of Alzheimer's disease, and FUMAD...
A Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Diroximel Fumarate (DRF) in Chinese and Caucasian Adult Healthy Participants
- First Posted Date
- 2021-11-19
- Last Posted Date
- 2022-07-05
- Lead Sponsor
- Biogen
- Target Recruit Count
- 32
- Registration Number
- NCT05127564
- Locations
- 🇳🇿
Research Site, Christchurch, New Zealand
A Study of Mass Balance, Pharmacokinetics, Metabolite Profile, and Metabolite Identification of BIIB122/DNL151 in Healthy Male Subjects
- First Posted Date
- 2021-11-15
- Last Posted Date
- 2021-12-07
- Lead Sponsor
- Biogen
- Target Recruit Count
- 7
- Registration Number
- NCT05119790
- Locations
- 🇺🇸
Pharmaron CPC, Baltimore, Maryland, United States
A Study to Assess the Clinical Validity of Konectom™ in Adults Living With Neuromuscular Disorders
- Conditions
- Interventions
- First Posted Date
- 2021-11-05
- Last Posted Date
- 2024-02-06
- Lead Sponsor
- Biogen
- Target Recruit Count
- 93
- Registration Number
- NCT05109637
- Locations
- 🇩🇪
LMU Klinikum Friedrich-Baur-Institute, Dept. of Neurology, Munich, Germany
🇩🇪Research Site, Heidelberg, Germany
A Study to Explore Association Patterns Between Digital Outcome Assessments From the Konectom™ Platform and Magnetic Resonance Imaging (MRI) Measures of Brain Tissue Damage
- First Posted Date
- 2021-11-03
- Last Posted Date
- 2024-05-17
- Lead Sponsor
- Biogen
- Target Recruit Count
- 200
- Registration Number
- NCT05106465
- Locations
- 🇩🇪
Multiple Sclerosis Centre, Dresden, Germany
An Observational Study of Aducanumab-avwa in Participants With Alzheimer's Disease in the US
- Conditions
- First Posted Date
- 2021-10-27
- Last Posted Date
- 2023-04-18
- Lead Sponsor
- Biogen
- Target Recruit Count
- 29
- Registration Number
- NCT05097131
- Locations
- 🇺🇸
Research Site, Canton, Ohio, United States
🇺🇸Imic, Inc., Palmetto Bay, Florida, United States
🇺🇸Northwest Neurology, Chicago, Illinois, United States
A Study of Diroximel Fumarate (DRF) in Adult Participants From the Asia-Pacific Region With Relapsing Forms of Multiple Sclerosis (RMS)
- Conditions
- Interventions
- First Posted Date
- 2021-10-19
- Last Posted Date
- 2024-08-26
- Lead Sponsor
- Biogen
- Target Recruit Count
- 100
- Registration Number
- NCT05083923
- Locations
- 🇨🇳
The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China
🇨🇳Beijing Hospital, Beijing, Beijing, China
🇨🇳Beijing Tiantan Hospital, Capital Medical University, Beijing, Beijing, China
A Study to Evaluate Higher Dose (HD) Nusinersen (BIIB058) in Participants With Spinal Muscular Atrophy Previously Treated With Risdiplam
- First Posted Date
- 2021-10-05
- Last Posted Date
- 2024-02-29
- Lead Sponsor
- Biogen
- Target Recruit Count
- 45
- Registration Number
- NCT05067790
- Locations
- 🇺🇸
Memorial Healthcare, Owosso, Michigan, United States
🇺🇸Columbia University, New York, New York, United States
🇺🇸Neurology Rare Disease Center, Denton, Texas, United States
An Observational Study Using Multimodal Sensors to Measure Cognitive Health in Adults and Distinguish Mild Cognitive Impairment From Normal Aging
- Conditions
- First Posted Date
- 2021-09-28
- Last Posted Date
- 2023-09-21
- Lead Sponsor
- Biogen
- Target Recruit Count
- 22720
- Registration Number
- NCT05058950
- Locations
- 🇺🇸
Virtual App-Based Study, Cambridge, Massachusetts, United States
MS PATHS COVID-19 Questionnaire Data Linkage Sub-Study
- Conditions
- First Posted Date
- 2021-09-28
- Last Posted Date
- 2023-04-18
- Lead Sponsor
- Biogen
- Target Recruit Count
- 1507
- Registration Number
- NCT05058729
- Locations
- 🇺🇸
Research Site, Columbus, Ohio, United States
Pediatric Spinal Muscular Atrophy (SMA) China Registry
- Conditions
- First Posted Date
- 2021-09-13
- Last Posted Date
- 2024-08-07
- Lead Sponsor
- Biogen
- Target Recruit Count
- 600
- Registration Number
- NCT05042921
- Locations
- 🇨🇳
Xiamen Maternal and Child Health Hospital, Xiamen, Fujian, China
🇨🇳The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China
🇨🇳Anhui Children's Hospital, Hefei, Anhui, China